“Current treatment options for SMA are revolutionary to the patients in need, and additional data—apart from safety and efficacy evidence from clinical trials—can help more comprehensively inform payers in their decision making,” said Omar...
“Current treatment options for SMA are revolutionary to the patients in need, and additional data—apart from safety and efficacy evidence from clinical trials—can help more comprehensively inform payers in their decision making,” said Omar...
“Current treatment options for...